Able Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$346K Sell
2,482
-95
-4% -$13.1K 0.08% 97
2026
Q2
$281K Buy
2,577
+468
+22% +$54.8K 0.06% 117
2026
Q1
$211K Buy
2,109
+207
+11% +$23.9K 0.06% 123
2025
Q4
$200K Buy
+1,902
New +$179K 0.06% 113
2025
Q1
– Sell
-2,014
Closed -$200K – 104
2024
Q4
$200K Buy
2,014
+68
+3% +$7.01K 0.13% 96
2024
Q3
$221K Hold
1,946
– – 0.17% 84
2024
Q2
$241K Buy
1,946
+11
+0.6% +$1.42K 0.2% 73
2024
Q1
$255K Sell
1,935
-10
-0.5% -$1.23K 0.22% 70
2023
Q4
$212K Buy
+1,945
New +$202K 0.19% 73

Other funds holding MRK

Able Wealth Management's MRK Position: Q3 2026 in Review

Able Wealth Management reduced its Merck (MRK) stake by 3.7% in Q3 2026, selling an estimated $13.1K and leaving 2,482 shares worth $346K. The position accounts for 0.08% of the portfolio, ranked #97.

Able Wealth Management first reported a position in MRK in Q4 2023 and has held it in 9 quarters since. 1,405 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Able Wealth Management held 2,482 shares of Merck worth $346K as of Q3 2026.
  • Able Wealth Management sold 95 Merck shares in Q3 2026, an estimated $13.1K.
  • Merck made up 0.08% of Able Wealth Management's portfolio in Q3 2026, its #97 holding.
  • Able Wealth Management first reported a position in Merck in Q4 2023 and has held it in 9 quarters since.
  • 1,405 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Able Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.